SUSAN BLANEY to Vascular Endothelial Growth Factor Receptor-2
This is a "connection" page, showing publications SUSAN BLANEY has written about Vascular Endothelial Growth Factor Receptor-2.
Connection Strength
0.147
-
Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2015 Sep; 62(9):1562-6.
Score: 0.122
-
Vascular-targeted photothermal therapy of an orthotopic murine glioma model. Nanomedicine (Lond). 2012 Aug; 7(8):1133-48.
Score: 0.025